Lv41
538 积分 2024-05-29 加入
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
1小时前
已完结
Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Trial
6小时前
已关闭
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship
1天前
已完结
Korea, Japan, Europe, and the United States: Why are guidelines for gastric cancer different?
18天前
已完结
The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review
25天前
已完结
Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice
25天前
已关闭
Utilization of point-of-care ultrasound to evaluate for enterovesical fistula
25天前
已关闭
Colonic involvement in inflammatory bowel diseases: spotlight on the role of magnetic resonance enterography
25天前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
1个月前
已完结
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
1个月前
已完结
皖公网安备34019202002308
